Improving quality of life for patients with terminal respiratory disease

References

• Heron M, Hoyert DL, Murphy SL et al. Deaths: Final Data for 2006. National Vital Statistics Reports, Centers For Disease Control. DHHS Publication No. (PHS) 2009–1120, 2008.
   Google Scholar
• Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet349, 1498–1504 (1997).
   PubMed Web of Science ®Google Scholar
• Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med.3(11), e442 (2005).
   Google Scholar
• Habraken JM, ter Riet G, Gore JM et al. Health-related quality of life in end-stage COPD and lung cancer patients. J. Pain Symptom Manage.37(6), 973–981 (2009).
   PubMed Web of Science ®Google Scholar
• Gilbert CR, Smith CM. Advanced parenchymal lung disease: quality of life and palliative care. Mt. Sin. J. Med.76, 63–70 (2009).
   PubMedGoogle Scholar
• Abrahm JL, Hansen-Flaschen J. Hospice care for patients with advanced lung disease. Chest121, 220–229 (2002).
   PubMed Web of Science ®Google Scholar
• Iglehart JK. A new era of for-profit hospice care – the Medicare benefit. N. Engl. J. Med.360, 2701–2703 (2009).
   PubMed Web of Science ®Google Scholar
• Rocker GM, Dodek PM, Heyland DK. Toward optimal end-of-life care for patients with advanced chronic obstructive pulmonary disease: insights from a multicentre study. Can. Respir. J.15(5), 249–254 (2008).
   PubMed Web of Science ®Google Scholar
• SUPPORT principal investigators. A controlled trial to improve care for seriously ill hospitalized patients: the Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments (SUPPORT). JAMA274(20), 1591–1598 (1995).
   PubMed Web of Science ®Google Scholar
• Claessens MT, Lynn J, Zhong Z et al. Dying with lung cancer or chronic obstructive pulmonary disease: insights from SUPPORT. J. Am. Geriatr. Soc.48(5), S91–S100 (2000).
   Google Scholar
• Goodridge D, Lawson J, Duggleby W et al. Health care utilization of patients with chronic obstructive pulmonary disease and lung cancer in the last 12 months of life. Respir. Med.102, 885–891 (2008).
   PubMed Web of Science ®Google Scholar
• Au DH, Udris EM, Fihn SD et al. Difference in health care utilization at the end of life among patients with chronic obstructive pulmonary disease and patients with lung cancer. Arch. Int. Med.166, 326–331 (2006).
   PubMed Web of Science ®Google Scholar
• Lynn J, Ely EW, Zhong Z et al. Living and dying with chronic obstructive pulmonary disease. J. Am. Geriatr. Soc.48(5 Suppl.), S91–S100 (2000).
   PubMed Web of Science ®Google Scholar
• Celli BR, Cote CG, Marin JM et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N. Engl. J. Med.350(10), 1005–1012 (2004).
   PubMed Web of Science ®Google Scholar
• Fox E, Landrum-McNiff K, Zhong Z et al. Evaluation of prognostic criteria for determining hospice eligibility in patients with advanced lung, heart, or liver disease. JAMA283, 1638–1645 (1999).
   Google Scholar
• Knaus WA, Harrell FE Jr, Lynn J et al. The SUPPORT prognostic model: objective estimates for survival for seriously ill hospitalized adults. Ann. Int. Med.122, 191–203 (1995).
   PubMed Web of Science ®Google Scholar
• Bjoraker JA, Ryu JH, Edwin MK et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med.157, 199–203 (1998).
   PubMed Web of Science ®Google Scholar
• Schwartz DA, Helmers RA, Galvin JR et al. Determinants of survival in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med.149, 450–454 (1994).
   PubMed Web of Science ®Google Scholar
• Gribbin J, Hubbard RB, Le Jeune I et al. Incidence and mortality of sarcoidosis and idiopathic pulmonary fibrosis in the UK. Thorax61, 980–985 (2006).
   PubMed Web of Science ®Google Scholar
• Christakis NA, Iwashyna TJ. Attitude and self-reported practice regarding prognostication in a national sample of internists. Arch. Int. Med.158, 2389–2395 (1998).
   PubMed Web of Science ®Google Scholar
• McNeely PD, Hébert PD, Dales RE et al. Deciding about mechanical ventilation in end-stage chronic obstructive pulmonary disease: how respirologists perceive their role. Can. Med. Assoc. J.156, 177–183 (1997).
   Google Scholar
• Hansen-Flaschen J. Chronic obstructive pulmonary disease: the last year of life. Respir. Care49, 90–97 (2004).
   PubMedGoogle Scholar
• Curtis JR. Palliative and end-of-life care for patients with severe COPD. Eur. Respir. J.32, 796–803 (2008).
   PubMed Web of Science ®Google Scholar
• Sawicki GS, Dill EJ, Asher D. Advance care planning in adults with cystic fibrosis. J. Palliat. Med.11(8), 1135–1141 (2008).
   PubMed Web of Science ®Google Scholar
• Philip JAM, Gold M, Sutherland S et al. End-of-life care in adults with cystic fibrosis. J. Palliat. Med.11(2), 198–203 (2008).
   PubMed Web of Science ®Google Scholar
• Dellon EP, Leigh MW, Yankaskas JR et al. Effects of lung transplantation on inpatient end of life care in cystic fibrosis. J. Cyst. Fibros.6(6), 396–402 (2007).
   PubMed Web of Science ®Google Scholar
• Heffner JE, Fahy B, Hilling L et al. Attitudes regarding advance directives among patients in pulmonary rehabilitation. Am. J. Respir. Crit. Care Med.154(6), 1735–1740 (1996).
   PubMedGoogle Scholar
• Knauft ME, Nielsen EL, Engelberg RA et al. Barriers and facilitators to communication about end-of-life care for patients with COPD. Chest127, 2188–2196 (2005).
   PubMed Web of Science ®Google Scholar
• Curtis JR, Engelberg RA, Nielsen EL et al. Patient-physician communication about end-of-life care for patients with severe COPD. Eur. Respir. J.24, 200–205 (2004).
   PubMed Web of Science ®Google Scholar
• Curtis JR, Wenrich MD, Carline JD et al. Patients’ perspectives on physician skill in end-of-life care: differences between patients with COPD, cancer, and AIDS. Chest122, 356–362 (2002).
   PubMed Web of Science ®Google Scholar
• West HF, Engelberg RA, Wenrich MD et al. Expressions of nonabandonment during the intensive care unit family conference. J. Palliat. Med.8, 797–807 (2005).
   PubMedGoogle Scholar
• Fried TR, Bradley EH, O’Leary J et al. Prognosis communication in serious illness: perceptions of older patients, caregivers, and clinicians. J. Am. Geriatr. Soc.51, 1398–1403 (2003).
   PubMed Web of Science ®Google Scholar
• Jones I, Kirby A, Ormiston P et al. The needs of patients dying of chronic obstructive pulmonary disease in the community. Fam. Pract.21, 310–313 (2004).
   PubMed Web of Science ®Google Scholar
• Paling J. Strategies to help patients understand risks. Br. Med. J.327, 745–748 (2003).
   PubMed Web of Science ®Google Scholar
• Edwards A, Elwyn G, Mulley A. Explaining risks: turning numerical data into meaningful pictures. Br. Med. J.324, 827–830 (2002).
   PubMed Web of Science ®Google Scholar
• Ehlenbach WJ, Barnato AE, Curtis JR et al. Epidemiologic study of in-hospital cardiopulmonary resuscitation in the elderly. N. Engl. J. Med.360, 2701–2701 (2009).
   PubMedGoogle Scholar
• Diem SJ, Lantos JD, Tulsky JA. Cardiopulmonary resuscitation on television: miracles and misinformation. N. Engl. J. Med.334, 1578–1582 (1996).
   PubMed Web of Science ®Google Scholar
• Nava S, Santoro C, Grassi M et al. The influence of the media on COPD patients’ knowledge regarding cardiopulmonary resuscitation. Int. J. Chron. Obst. Pulmon. Dis.3, 295–300 (2008).
   PubMedGoogle Scholar
• Murphy DJ, Burrows D, Santilli S. The influence of the probability of survival on patients’ preferences regarding cardiopulmonary resuscitation. N. Engl. J. Med.330, 545–549 (1994).
   PubMed Web of Science ®Google Scholar
• Lynn J, Teno JM, Phillips RS et al. Perceptions by family members of the dying experience of older and seriously ill patients. SUPPORT investigators. Study to understand prognoses and preferences for outcomes and risks of treatments. Ann. Intern. Med.126(2), 97–106 (1997).
   PubMed Web of Science ®Google Scholar
• Elkington H, White P, Addington-Hall J et al. The healthcare needs of chronic obstructive pulmonary disease patients in the last year of life. Palliat. Med.19(6), 485–491 (2005).
   PubMed Web of Science ®Google Scholar
• Luce JM, Luce JA. Management of dyspnea in patients with far-advanced lung disease. JAMA285(10), 1331–1337 (2001).
   PubMedGoogle Scholar
• Gallagher R, Roberts D. A systematic review of oxygen and airflow effect on relief of dyspnea at rest in patients with advanced disease of any cause. J. Pain Palliat. Care Pharmacother.18(4), 3–15 (2004).
   PubMedGoogle Scholar
• Dewan NA, Bell CW. Effect of low flow and high flow oxygen delivery on exercise tolerance and sensation of dyspnea: a study comparing the transtracheal catheter and nasal prongs. Chest105, 1061–1065 (1994).
   PubMed Web of Science ®Google Scholar
• Booth S, Kelly MJ, Cox NP et al. Does oxygen help dyspnea in patients with cancer? Am. J. Respir. Crit. Care Med.153, 1515–1518 (1996).
   PubMed Web of Science ®Google Scholar
• Schwarzstein RM, Lahive K, Pope A et al. Cold facial stimulation reduces breathlessness induced in normal subjects. Am. Rev. Respir. Dis.136(1), 58–61 (1987).
   PubMedGoogle Scholar
• Jennings AL, Davies AN, Higgins JP et al. Opioids for the palliation of breathlessness in terminal illness. Cochrane Database Syst. Rev.4, CD002066 (2001).
   Google Scholar
• Foral PA, Malesker MA, Huerta G et al. Nebulized opioids use in COPD. Chest125(2), 363–365 (2004).
   PubMedGoogle Scholar
• Wilcock A, Walter A, Manderson C et al. Randomised, placebo controlled trial of nebulised furosemide for breathlessness in patients with cancer. Thorax63, 872–875 (2008).
   PubMedGoogle Scholar
• Viola R, Kiteley C, Lloyd NS et al. The management of dyspnea in cancer patients: a systematic review. Supp. Care Cancer16, 329–337 (2008).
   PubMed Web of Science ®Google Scholar
• Bausewein C, Booth S, Gysels M et al. Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases. Cochrane Database Syst. Rev.16, CD005623 (2008).
   Google Scholar
• Zech DF, Grond S, Lynch J et al. Validation of World Health Organization guidelines for cancer pain relief: a 10 year prospective study. Pain63, 65–76 (1995).
   PubMed Web of Science ®Google Scholar
• Clemens KE, Klaschik E. Effect of hydromorphone on ventilation in palliative care patients with dyspnea. Supp. Care Cancer16, 93–99 (2008).
   PubMed Web of Science ®Google Scholar
• Wee B, Hillier R. Interventions for noisy breathing in patients near to death. Cochrane Database Syst. Rev.23(1), CD005177 (2008).
   Google Scholar
• Wildiers H, Dhaenekint C, Demeulenaere P et al. Atropine, hyoscine butylbromide, or scopolamine are equally effective for the treatment of death rattle in terminal care. J. Pain Symptom Manage.38, 124–133, (2009).
   PubMed Web of Science ®Google Scholar
• Bickel K, Arnold RM. Death rattle and oral secretions – second edition #109. J. Palliat. Med.11, 1040–1041 (2008).
   PubMedGoogle Scholar
• Kunik ME, Roundy K, Veazey C et al. Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest127, 1205–1211 (2005).
   PubMed Web of Science ®Google Scholar
• Van Manen JG, Bindels PJE, Dekker FW et al. Risk of depression in patiens with chronic obstructive pulmonary disease and its determinants. Thorax57, 412–416 (2002).
   PubMed Web of Science ®Google Scholar
• Gore JM, Brophy CJ, Greenstone MA. How well do we care for patients with end stage chronic obstructive pulmonary disease (COPD)? A comparison of palliative care and quality of life in COPD and lung cancer. Thorax55, 1000–1006 (2000).
   PubMed Web of Science ®Google Scholar
• Maurer J, Rebbapragada V, Borson S et al. Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest134, 43S–56S (2008).
   PubMed Web of Science ®Google Scholar
• Stapleton RD, Nielsen EL, Engelberg RA et al. Association of depression and life-sustaining treatment preferences in patients with COPD. Chest127, 328–334 (2005).
   PubMed Web of Science ®Google Scholar
• Breitbart W, Alici Y. Agitation and delirium at the end of life: ‘We couldn’t manage him’. JAMA300, 2898–2910 (2008).
   PubMed Web of Science ®Google Scholar
• Breitbart W, Marotta R, Platt M et al. A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am. J. Psychiatry153, 231–237 (1996).
   PubMed Web of Science ®Google Scholar
• Puchalski CM. Spirituality and end-of-life care: a time for listening and caring. J. Palliat. Med.5, 289–294 (2002).
   PubMedGoogle Scholar
• Sulmasy DP. Spiritual issues in the care of dying patients: “It’s okay between me and God”. JAMA296(11), 1385–1392 (2006).
   PubMed Web of Science ®Google Scholar
• Morrison LJ, Scott JO, Block SD et al. Developing initial competency-based outcomes for the hospice and palliative medicine subspecialist: Phase I of the hospice and palliative medicine competencies project. J. Palliat. Med.10, 313–330 (2007).
   PubMed Web of Science ®Google Scholar